ARG1 and metabolic dysfunction-associated steatohepatitis: Clinicopathological analysis demonstrated significant correlation of negative ARG1 expression with poor tumor differentiation (p = 0.04) in human metabolic syndrome/NASH-associated but not in HCV+ HCCs (Table 2).